The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site
Clinical trial NCT06095206 · COMPLETED
Trial details
- NCT number
- NCT06095206
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2023-11-07
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.